175205-63-7 Usage
Uses
Used in Pharmaceutical Industry:
3-Chloromethyl-5-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole is used as a key intermediate in the synthesis of new drugs for its potential biological activities, including antifungal, antibacterial, antiviral, and anticancer properties. Its unique structure allows for the development of compounds with enhanced therapeutic effects and selectivity.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Chloromethyl-5-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole is utilized as a building block for the creation of novel agrochemicals with improved efficacy and selectivity against pests and diseases. Its chemical properties enable the design of compounds with targeted modes of action and reduced environmental impact.
Used in Materials Science:
3-Chloromethyl-5-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole is employed in materials science as a component in the development of advanced materials with specific properties. Its incorporation into polymers and other materials can lead to enhanced performance characteristics, such as improved thermal stability, flame retardancy, or specific optical and electronic properties.
Overall, the versatility of 3-Chloromethyl-5-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole stems from its unique structural features and the potential for its application across multiple industries, making it a valuable compound for ongoing research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 175205-63-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,2,0 and 5 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 175205-63:
(8*1)+(7*7)+(6*5)+(5*2)+(4*0)+(3*5)+(2*6)+(1*3)=127
127 % 10 = 7
So 175205-63-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H7NO3/c1-2-10-6(8)5-3-9-4-7-5/h3-4H,2H2,1H3
175205-63-7Relevant academic research and scientific papers
Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonists
Elzein, Elfatih,Kalla, Rao,Li, Xiaofen,Perry, Thao,Parkhill, Eric,Palle, Venkata,Varkhedkar, Vaibahv,Gimbel, Art,Zeng, Dewan,Lustig, David,Leung, Kwan,Zablocki, Jeff
, p. 302 - 306 (2007/10/03)
A series of new 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)- xanthine derivatives as A2B-AdoR antagonists have been synthesized and evaluated for their binding affinities for the A2B, A 1, A2A, and A3-AdoRs. 8-(1-((3-phenyl-1,2,4- oxadiazol-5-yl)methyl)-1H-pyrazol-4-yl)-1,3-dipropyl-1H-purine-2,6(3H,7H)-dione (4) displayed high affinity (Ki = 1 nM) and selectivity for the A2B-AdoR versus A1, A2A, and A 3-AdoRs (A1/A2B, A2A/A2B, and A3/A2B selectivity ratios of 370, 1100, and 480, respectively). The synthesis and SAR of this novel class of compounds are presented herein.
The discovery of a selective, high affinity A2B adenosine receptor antagonist for the potential treatment of asthma
Zablocki, Jeff,Kalla, Rao,Perry, Thao,Palle, Venkata,Varkhedkar, Vaibhav,Xiao, Dengming,Piscopio, Anthony,Maa, Tenning,Gimbel, Art,Hao, Jia,Chu, Nancy,Leung, Kwan,Zeng, Dewan
, p. 609 - 612 (2007/10/03)
Adenosine has been suggested to play a role in asthma, possibly via activation of A2B adenosine receptors on mast cells and other pulmonary cells. We describe our initial efforts to discover a xanthine based selective A2B AdoR antagonist that resulted in the discovery of CVT-5440, a high affinity A2B AdoR antagonist with good selectivity (A2B AdoR Ki = 50 nM, selectivity A1 > 200: A2A > 200: A3 > 167).
